Clinical Trial Update: A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 clinical trial evaluating zolbetuximab in combination with pembrolizumab and chemotherapy for gastric cancer and gastroesophageal j…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Phase 3 | Status: RECRUITING